Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective PCI

被引：0
|
作者：
Rudez, G. [1 ]
Bouman, H. J. [2 ]
van, Werkum J. W. [2 ]
Leebeek, F. W. G. [1 ]
Kruit, A. [3 ]
Ruven, H. J. T. [3 ]
ten Berg, J. M. [2 ]
de Maat, M. P. M. [1 ]
Hackeng, C. M. [3 ]
机构：
[1] Erasmus Univ, Med Ctr, Hematol, Rotterdam, Netherlands
[2] St Antonius Hosp, Cardiol, Nieuwegein, Netherlands
[3] St Antonius Hosp, Clin Chem, Nieuwegein, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC-MO-133
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [11] Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene
    Staritz, Peter
    Kurz, Kerstin
    Stoll, Monika
    Giannitsis, Evangelos
    Katus, Hugo A.
    Ivandic, Boris T.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (03) : 341 - 345
  • [12] Evaluation of On-Clopidogrel platelet reactivity overtime, SYNTAX SCORE, genetic polymorphisms and their relationship to one year clinical outcomes in STEMI patients undergoing PCI
    Erathi, Harsha V.
    Durgaprasad, Rajasekhar
    Velam, Vanjakshamma
    Sarma, P. V. G. K.
    Rodda, Madhavi
    Kapil, C.
    Kanavath, Sreedhar N.
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (01): : 16 - 25
  • [13] Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivityP2RY12 基因单倍体分型对急性冠脉综合征患者氯吡格雷用药后血小板反应性的影响
    Xiao-yan Nie
    Jun-lei Li
    Yong Zhang
    Yang Xu
    Xue-li Yang
    Yu Fu
    Guang-kai Liang
    Yun Lu
    Jian Liu
    Lu-wen Shi
    Journal of Zhejiang University-SCIENCE B, 2017, 18 : 37 - 47
  • [14] Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
    Li, Miaonan
    Wang, Hongju
    Xuan, Ling
    Shi, Xiaojun
    Zhou, Tong
    Zhang, Ningru
    Huang, Yuli
    MEDICINE, 2017, 96 (14)
  • [15] Association of P2RY12 polymorphisms with eosinophil and platelet activation in patients with aspirin-exacerbated respiratory disease
    Losol, Purevsuren
    Palikhe, Nami Shrestha
    Lee, Ji Won
    Palikhe, Sailesh
    Kim, Mi-Ae
    Yang, Eun-Mi
    Choi, Hyunna
    Choi, Gil-Soon
    Kim, Seung-Hyun
    Park, Hae-Sim
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (05) : 423 - +
  • [16] Effects of endurance training on hsa-miR-223, P2RY12 receptor expression and platelet function in type 2 diabetic patients
    Taghizadeh, Mahmoudreza
    Ahmadizad, Sajad
    Naderi, Mahmood
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2018, 68 (04) : 391 - 399
  • [17] The Effect of New P2Y12 Receptor Antagonist, Ticagrelor, On Platelet Reactivity in Patients With Clopidogrel Resistance Undergoing Neuroendovascular Procedures
    Jahngir, Muhammad
    Qureshi, Adnan
    Akinci, Yasemin
    Singh, Baljinder
    NEUROLOGY, 2019, 92 (15)
  • [18] Optimizing platelet P2Y12 inhibition for patients undergoing PCI
    Steinhubl, Steven
    Roe, Matthew T.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (02): : 188 - 203
  • [19] Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors
    Thomas, Mark R.
    Storey, Robert F.
    VASCULAR PHARMACOLOGY, 2016, 84 : 25 - 27
  • [20] Prognostic Impacts, Predictors and Genetic Determinants of High On-treatment Platelet Reactivity to Aspirin and Clopidogrel and in Patients Undergoing Elective PCI in Japanese Population
    Fukino, Keiko
    Sat, Taiki
    Ishibashi, Midori
    Yabushita, Hiroto
    Warsawa, Takayuki
    Watanabe, Yusuke
    Mitomo, Satoru
    Matsumoto, Takahiro
    Naganuma, Toru
    Sato, Tomohiko
    Kobayashi, Tsuyoshi
    Fujino, Yusuke
    Takagi, Keusuke
    Ishiguro, Hisaaki
    Tahara, Satoko
    Kurita, Naoyuki
    Nakamura, Shotaro
    Hozawa, Koji
    Nakamura, Sunao
    CIRCULATION, 2014, 130
12345